期刊论文

Advances in the Application of Multimodal Magnetic Resonance Imaging in HER-2-Positive Breast Cancer

中文

中国CT和MRI杂志

1672-5131

2023

21

07

177-179

10.3969/j.issn.1672-5131.2023.07.059

本校为第一机构

HER-2(人表皮生长因子受体-2)阳性乳腺癌是指在基因检测中,HER-2基因表达为阳性的乳腺癌。通常而言,HER-2阳性乳腺癌预示着分化较差的肿瘤、较高的侵袭性、易转移和复发、患者预后一般较差。因此,对于HER-2阳性...展开更多 HER-2(人表皮生长因子受体-2)阳性乳腺癌是指在基因检测中,HER-2基因表达为阳性的乳腺癌。通常而言,HER-2阳性乳腺癌预示着分化较差的肿瘤、较高的侵袭性、易转移和复发、患者预后一般较差。因此,对于HER-2阳性乳腺癌患者而言,早期及有效的临床诊断与治疗显得格外重要。磁共振成像拥有着优秀的软组织分辨率,不仅可以从多参数、多方位进行观察肿瘤形态学结构,亦可从血流动力、...

HER-2(human epidermal growth factor receptor-2)positive breast cancer is defined as breast cancer with positive HER-2 gene expression in genetic testing.In general,HER-2-positive breast cancer predicts poorly differentiated tumors,higher aggressiveness,susceptibility to...MORE HER-2(human epidermal growth factor receptor-2)positive breast cancer is defined as breast cancer with positive HER-2 gene expression in genetic testing.In general,HER-2-positive breast cancer predicts poorly differentiated tumors,higher aggressiveness,susceptibility to metastasis and recurrence,and generally poor patien...